Publications
457 publications
- Date
- Relevance
-
Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia
The National Health Care Institute issued a package advice on the medicinal product evolocumab (Repatha®) for the treatment of ...
-
Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis
Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL ...
-
Zinnige Zorg room for improvement report - Chest pain (Suspected) Stable Angina Pectoris
The motto of the National Health Care Institute is "Taking care of good health care: no more and no less than necessary". Every ...
-
Zinnige Zorg room for improvement report - Appropriate use of expensive medicines in cases of metastatic renal cell carcinoma
Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...
-
Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)
The National Health Care Institute has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone ...
-
Programme ‘Outcome Information for Shared Decision-Making’ - factsheet
-
Project: ‘ICHOM as an accelerator for outcome information’ - factsheet
-
Glycerol phenylbutyrate (Ravicti®) for the treatment of urea-cycle disorders
The National Health Care Institute has carried out an assessment of the medicinal product glycerol phenylbutyrate (Ravicti®) for ...
-
Zinnige Zorg room for improvement report - In-depth phase neoplasms: care during the final stage of life of patients with incurable intestinal or lung cancer
The final stage of life is one in which a patient is of an advanced age or has a disease and/or is in a phase of a disease that ...
-
Cetuximab (Erbitux®) for the treatment of metastatic colorectal cancer
The National Health Care Institute has carried out a re-assessment of the medicinal product cetuximab (Erbitux®), whereby they ...